Available IPD datapackage for study 'A Randomized, Open-Label, Parallel Group Comparative Study of Paliperidone Palmitate (50, 100, 150 mg eq) and Risperidone LAI (25, 37.5, or 50 mg) in Subjects With Schizophrenia'
收藏DataCite Commons2024-07-12 更新2024-07-13 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00004751.1
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare the efficacy of paliperidone palmitate and risperidone long acting injection (LAI) in participants with schizophrenia (psychiatric disorder with symptoms of emotional instability, detachment from reality, often with delusions and hallucinations, and withdrawal into the self) along with safety and tolerability.
提供机构：
Vivli
创建时间：
2024-07-12
